Previous work reported that an estimated 25% of the circulating inflammatory monocytes will differentiate into migrating DCs33, thus we explored cDC, CD14+ monocyte, and CD16+ monocyte receptor–ligand pairing in both MG patients and HCs, which may represent the differentiation of myeloid cells. The gene discussed is CD14; the disease is myasthenia gravis.